Franklin Resources Inc Rapt Therapeutics, Inc. Transaction History

Franklin Resources Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$6.87 - $26.45 $177,774 - $684,446	25,877 New	25,877 $232,000
Q3 2022 Nov 14, 2022	BUY	$17.96 - $30.46 $155,803 - $264,240	8,675 New	8,675 $209,000
Q2 2022 Aug 11, 2022	SELL	$10.26 - $23.59 $130,353 - $299,710	-12,705 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$17.02 - $40.22 $289 - $683	17 Added 0.13%	12,705 $280,000
Q4 2021 Feb 11, 2022	SELL	$29.5 - $39.5 $354 - $474	-12 Reduced 0.09%	12,688 $466,000
Q3 2021 Nov 12, 2021	BUY	$29.86 - $39.47 $379,222 - $501,269	12,700 New	12,700 $394,000

105

27.1M

26.7K

2.4K

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $35.6M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.